Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.66
Delayed Data
As of Aug 28
 +0.32 / +5.05%
Today’s Change
4.40
Today|||52-Week Range
15.24
-33.07%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close6.34
Today’s open6.31
Day’s range6.31 - 6.92
Volume46,284
Average volume (3 months)105,341
Market cap$166.8M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-72.00%
Earnings growth (this year)+72.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+70.18%
P/E ratioNM
Price/Sales34.71
Price/Book39.16

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.23+1.59%
NUTRNutraceutical Intern...0.000.00%
NATRNatures Sunshine Pro...+0.15+1.26%
ISRIsoRay Inc+0.05+3.65%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateNovember 18, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.1M
Annual profit (last year)-$9.3M
Net profit margin-226.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Partner Offers